Cargando…

Clonal expansion of Mycobacterium tuberculosis isolates and coexisting drug resistance in patients newly diagnosed with pulmonary tuberculosis in Hanoi, Vietnam

BACKGROUND: Newly diagnosed patients without anti-tuberculosis (TB) treatment histories have not often undergone drug susceptibility testing (DST), but have received the standard treatment regimen without information about their DST profiles in many countries with inadequate resources. METHODS: We c...

Descripción completa

Detalles Bibliográficos
Autores principales: Hung, Nguyen Van, Ando, Hiroki, Thuy, Tran Thi-Bich, Kuwahara, Tomoko, Hang, Nguyen Thi-Le, Sakurada, Shinsaku, Thuong, Pham Huu, Lien, Luu Thi, Keicho, Naoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228276/
https://www.ncbi.nlm.nih.gov/pubmed/24188178
http://dx.doi.org/10.1186/1756-0500-6-444
_version_ 1782343949544849408
author Hung, Nguyen Van
Ando, Hiroki
Thuy, Tran Thi-Bich
Kuwahara, Tomoko
Hang, Nguyen Thi-Le
Sakurada, Shinsaku
Thuong, Pham Huu
Lien, Luu Thi
Keicho, Naoto
author_facet Hung, Nguyen Van
Ando, Hiroki
Thuy, Tran Thi-Bich
Kuwahara, Tomoko
Hang, Nguyen Thi-Le
Sakurada, Shinsaku
Thuong, Pham Huu
Lien, Luu Thi
Keicho, Naoto
author_sort Hung, Nguyen Van
collection PubMed
description BACKGROUND: Newly diagnosed patients without anti-tuberculosis (TB) treatment histories have not often undergone drug susceptibility testing (DST), but have received the standard treatment regimen without information about their DST profiles in many countries with inadequate resources. METHODS: We collected 346 clinical isolates from previously untreated patients with smear-positive active TB in Hanoi, the capital of Vietnam. Of these, 339 were tested for susceptibility to four first-line anti-TB drugs, including isoniazid (INH), rifampicin (RMP), streptomycin (SM), and ethambutol (EMB), using the proportion method. A pyrazinamidase (PZase) test was used to assess pyrazinamide (PZA) resistance. Results of the culture-based drug susceptibility tests were confirmed by those from reverse hybridization-based line probe assays (LiPAs) that detected mutations associated with RMP, INH, PZA, and fluoroquinolone (FQ) resistance. To investigate a diversity of these strains, IS6110-probed restriction fragment length polymorphisms (RFLPs) were analyzed. Nucleotide sequences for furA-katG and fabG1-inhA operons, transcription units responsible for INH resistance, were also determined. RESULTS: Of the isolates tested, 127 (37.5%) were resistant to at least one of the four drugs, which included 93 (27.4%) isolates that were resistant to INH. RFLP analysis identified four clusters defined by similarity of the band patterns, which accounted for 46.1% of the tested isolates. Among the clustered isolates, 37.7% were resistant to INH, most of which (85.4%) carried a g944c mutation, which causes an S315T amino acid substitution, in the katG gene. CONCLUSIONS: Our results suggest that drug-resistant strains, particularly those with INH resistance characterized by a single mutation, S315T, are spreading in Hanoi, Vietnam. When RMP resistance is combined with this setting, patients are not easily cured by conventional short-term treatment. We will need to carefully monitor these trends and search for the origins and transmission routes of these strains.
format Online
Article
Text
id pubmed-4228276
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42282762014-11-13 Clonal expansion of Mycobacterium tuberculosis isolates and coexisting drug resistance in patients newly diagnosed with pulmonary tuberculosis in Hanoi, Vietnam Hung, Nguyen Van Ando, Hiroki Thuy, Tran Thi-Bich Kuwahara, Tomoko Hang, Nguyen Thi-Le Sakurada, Shinsaku Thuong, Pham Huu Lien, Luu Thi Keicho, Naoto BMC Res Notes Research Article BACKGROUND: Newly diagnosed patients without anti-tuberculosis (TB) treatment histories have not often undergone drug susceptibility testing (DST), but have received the standard treatment regimen without information about their DST profiles in many countries with inadequate resources. METHODS: We collected 346 clinical isolates from previously untreated patients with smear-positive active TB in Hanoi, the capital of Vietnam. Of these, 339 were tested for susceptibility to four first-line anti-TB drugs, including isoniazid (INH), rifampicin (RMP), streptomycin (SM), and ethambutol (EMB), using the proportion method. A pyrazinamidase (PZase) test was used to assess pyrazinamide (PZA) resistance. Results of the culture-based drug susceptibility tests were confirmed by those from reverse hybridization-based line probe assays (LiPAs) that detected mutations associated with RMP, INH, PZA, and fluoroquinolone (FQ) resistance. To investigate a diversity of these strains, IS6110-probed restriction fragment length polymorphisms (RFLPs) were analyzed. Nucleotide sequences for furA-katG and fabG1-inhA operons, transcription units responsible for INH resistance, were also determined. RESULTS: Of the isolates tested, 127 (37.5%) were resistant to at least one of the four drugs, which included 93 (27.4%) isolates that were resistant to INH. RFLP analysis identified four clusters defined by similarity of the band patterns, which accounted for 46.1% of the tested isolates. Among the clustered isolates, 37.7% were resistant to INH, most of which (85.4%) carried a g944c mutation, which causes an S315T amino acid substitution, in the katG gene. CONCLUSIONS: Our results suggest that drug-resistant strains, particularly those with INH resistance characterized by a single mutation, S315T, are spreading in Hanoi, Vietnam. When RMP resistance is combined with this setting, patients are not easily cured by conventional short-term treatment. We will need to carefully monitor these trends and search for the origins and transmission routes of these strains. BioMed Central 2013-11-05 /pmc/articles/PMC4228276/ /pubmed/24188178 http://dx.doi.org/10.1186/1756-0500-6-444 Text en Copyright © 2013 Hung et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Hung, Nguyen Van
Ando, Hiroki
Thuy, Tran Thi-Bich
Kuwahara, Tomoko
Hang, Nguyen Thi-Le
Sakurada, Shinsaku
Thuong, Pham Huu
Lien, Luu Thi
Keicho, Naoto
Clonal expansion of Mycobacterium tuberculosis isolates and coexisting drug resistance in patients newly diagnosed with pulmonary tuberculosis in Hanoi, Vietnam
title Clonal expansion of Mycobacterium tuberculosis isolates and coexisting drug resistance in patients newly diagnosed with pulmonary tuberculosis in Hanoi, Vietnam
title_full Clonal expansion of Mycobacterium tuberculosis isolates and coexisting drug resistance in patients newly diagnosed with pulmonary tuberculosis in Hanoi, Vietnam
title_fullStr Clonal expansion of Mycobacterium tuberculosis isolates and coexisting drug resistance in patients newly diagnosed with pulmonary tuberculosis in Hanoi, Vietnam
title_full_unstemmed Clonal expansion of Mycobacterium tuberculosis isolates and coexisting drug resistance in patients newly diagnosed with pulmonary tuberculosis in Hanoi, Vietnam
title_short Clonal expansion of Mycobacterium tuberculosis isolates and coexisting drug resistance in patients newly diagnosed with pulmonary tuberculosis in Hanoi, Vietnam
title_sort clonal expansion of mycobacterium tuberculosis isolates and coexisting drug resistance in patients newly diagnosed with pulmonary tuberculosis in hanoi, vietnam
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228276/
https://www.ncbi.nlm.nih.gov/pubmed/24188178
http://dx.doi.org/10.1186/1756-0500-6-444
work_keys_str_mv AT hungnguyenvan clonalexpansionofmycobacteriumtuberculosisisolatesandcoexistingdrugresistanceinpatientsnewlydiagnosedwithpulmonarytuberculosisinhanoivietnam
AT andohiroki clonalexpansionofmycobacteriumtuberculosisisolatesandcoexistingdrugresistanceinpatientsnewlydiagnosedwithpulmonarytuberculosisinhanoivietnam
AT thuytranthibich clonalexpansionofmycobacteriumtuberculosisisolatesandcoexistingdrugresistanceinpatientsnewlydiagnosedwithpulmonarytuberculosisinhanoivietnam
AT kuwaharatomoko clonalexpansionofmycobacteriumtuberculosisisolatesandcoexistingdrugresistanceinpatientsnewlydiagnosedwithpulmonarytuberculosisinhanoivietnam
AT hangnguyenthile clonalexpansionofmycobacteriumtuberculosisisolatesandcoexistingdrugresistanceinpatientsnewlydiagnosedwithpulmonarytuberculosisinhanoivietnam
AT sakuradashinsaku clonalexpansionofmycobacteriumtuberculosisisolatesandcoexistingdrugresistanceinpatientsnewlydiagnosedwithpulmonarytuberculosisinhanoivietnam
AT thuongphamhuu clonalexpansionofmycobacteriumtuberculosisisolatesandcoexistingdrugresistanceinpatientsnewlydiagnosedwithpulmonarytuberculosisinhanoivietnam
AT lienluuthi clonalexpansionofmycobacteriumtuberculosisisolatesandcoexistingdrugresistanceinpatientsnewlydiagnosedwithpulmonarytuberculosisinhanoivietnam
AT keichonaoto clonalexpansionofmycobacteriumtuberculosisisolatesandcoexistingdrugresistanceinpatientsnewlydiagnosedwithpulmonarytuberculosisinhanoivietnam